Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
53,220,691
-
Share change
-
-450,811
-
Total reported value
-
$6,412,231,577
-
Put/Call ratio
-
176%
-
Price per share
-
$120.51
-
Number of holders
-
703
-
Value change
-
-$18,208,247
-
Number of buys
-
250
-
Number of sells
-
275
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2019
As of 31 Dec 2019,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
703 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,220,691 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, GOLDMAN SACHS GROUP INC, BARCLAYS PLC, UBS Group AG, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, BNP PARIBAS ARBITRAGE, SA, TWO SIGMA INVESTMENTS, LP, and ROYAL BANK OF CANADA.
This page lists
703
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.